KOREA WHO
-
-
-
CEO of DuChemBio
Kim Sang-woo
Broad Expertise, Expanding Dementia Diagnostic Capacity
-
Last Updated on Nov 21, 2025
-
CEO of DuChemBio
Life Summary
Kim Sang-woo is the CEO of DuChemBio.
He is focusing on expanding production capacity to meet the rapidly growing demand for radiopharmaceuticals.
He was born in July 1972.
He graduated from Yonsei University with a degree in Business Administration and worked at J.P. Morgan.
He later served as a strategy consultant at Monitor Group and SoftBank NPlatform.
He worked at Sampyo as a sales branch manager and deputy head of corporate planning and management, and at Korea Investment & Securities as head of the international division and head of the Hong Kong subsidiary. He was then appointed CEO of KD Media and Yesshop.
He joined DuChemBio in 2020 and was appointed CEO in 2023.
He has built broad experience across various industries, including finance, consulting, media, and bio.
He combines strategic and financial insight with strong capabilities in business development and organizational management.
#DuChemBio #radiopharmaceuticals #KimSangwoo #biotech #KoreanCEO #businessstrategy #productioncapacity #careerprofile #lifesciences #Kbio
He is focusing on expanding production capacity to meet the rapidly growing demand for radiopharmaceuticals.
He was born in July 1972.
He graduated from Yonsei University with a degree in Business Administration and worked at J.P. Morgan.
He later served as a strategy consultant at Monitor Group and SoftBank NPlatform.
He worked at Sampyo as a sales branch manager and deputy head of corporate planning and management, and at Korea Investment & Securities as head of the international division and head of the Hong Kong subsidiary. He was then appointed CEO of KD Media and Yesshop.
He joined DuChemBio in 2020 and was appointed CEO in 2023.
He has built broad experience across various industries, including finance, consulting, media, and bio.
He combines strategic and financial insight with strong capabilities in business development and organizational management.
#DuChemBio #radiopharmaceuticals #KimSangwoo #biotech #KoreanCEO #businessstrategy #productioncapacity #careerprofile #lifesciences #Kbio